Teladoc Mergers and Acquisitions Presentation Deck
Substantial Revenue and Cost Synergy Opportunities
~20%
International
sales
Cross-Sell of Existing Products
Sell Teladoc and Livongo products across existing direct-to-employer and
health plan relationships
●
Expand Livongo into Teladoc Small & Medium Business, Managed Medicaid,
and Hospital & Health System segments
Develop an integrated Behavioral Health product with complementary Teladoc
and Livongo assets and distribute within both existing customer bases
Referrals
Increase enrollment and utilization by referring individuals across
Teladoc and Livongo products (when they have access to both), and
amplify overall engagement and retention
International Sales
Use Teladoc international salesforce to drive sales of Livongo products
to international insurers, employers and governments
OpEx Reduction
Reduce run-rate costs by combining the two entities
Teladoc Livongo®
HEALTH
~25%
Referrals
O Teladoc Health, Inc. All rights reserved.
$500M
in annual revenue
synergies by 2025
$60M
in annual OpEx synergies by 2022
~55%
Cross-sell
20View entire presentation